220 related articles for article (PubMed ID: 11997877)
1. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.
Verney C; Lebrand C; Gaspar P
Anat Rec; 2002 Jun; 267(2):87-93. PubMed ID: 11997877
[TBL] [Abstract][Full Text] [Related]
2. Transient developmental expression of monoamine transporters in the rodent forebrain.
Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
[TBL] [Abstract][Full Text] [Related]
3. Transitory uptake of serotonin in the developing sensory pathways of the common marmoset.
Lebrand C; Gaspar P; Nicolas D; Hornung JP
J Comp Neurol; 2006 Dec; 499(4):677-89. PubMed ID: 17029254
[TBL] [Abstract][Full Text] [Related]
4. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic expression of monoamines and GABA in the early development of human telencephalon, transient or not transient.
Verney C
J Chem Neuroanat; 2003 Dec; 26(4):283-92. PubMed ID: 14729130
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical development of the hippocampal region in the fetal rhesus monkey. I. Early appearance of peptides, calcium-binding proteins, DARPP-32, and monoamine innervation in the entorhinal cortex during the first half of gestation (E47 to E90).
Berger B; Alvarez C; Goldman-Rakic PS
Hippocampus; 1993 Jul; 3(3):279-305. PubMed ID: 8353610
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome patients start early prenatal life with normal cholinergic, monoaminergic and serotoninergic innervation.
Lubec B; Yoo BC; Dierssen M; Balic N; Lubec G
J Neural Transm Suppl; 2001; (61):303-10. PubMed ID: 11771753
[TBL] [Abstract][Full Text] [Related]
9. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
Hoffman BJ; Hansson SR; Mezey E; Palkovits M
Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
[TBL] [Abstract][Full Text] [Related]
10. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes.
Anlauf M; Schäfer MK; Eiden L; Weihe E
J Comp Neurol; 2003 Apr; 459(1):90-111. PubMed ID: 12629668
[TBL] [Abstract][Full Text] [Related]
11. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
Synapse; 1997 Jun; 26(2):194-8. PubMed ID: 9131778
[TBL] [Abstract][Full Text] [Related]
12. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
[TBL] [Abstract][Full Text] [Related]
13. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT).
Martel F; Monteiro R; Lemos C
J Pharmacol Exp Ther; 2003 Jul; 306(1):355-62. PubMed ID: 12682218
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical development of the hippocampal region in the fetal rhesus monkey. II. Immunocytochemistry of peptides, calcium-binding proteins, DARPP-32, and monoamine innervation in the entorhinal cortex by the end of gestation.
Berger B; Alvarez C
Hippocampus; 1994 Feb; 4(1):85-114. PubMed ID: 7914799
[TBL] [Abstract][Full Text] [Related]
15. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study.
Galineau L; Kodas E; Guilloteau D; Vilar MP; Chalon S
Neurosci Lett; 2004 Jun; 363(3):266-71. PubMed ID: 15182957
[TBL] [Abstract][Full Text] [Related]
18. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
[TBL] [Abstract][Full Text] [Related]
19. Transient expression of the serotonin transporter in the developing mouse thalamocortical system.
Brüning G; Liangos O
Acta Histochem; 1997 Mar; 99(1):117-21. PubMed ID: 9150804
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
